Understanding Your Weight Management Treatment Options
The Core Difference Between Wegovy and Mounjaro Mechanisms
The fundamental difference between Wegovy and Mounjaro lies in their active ingredients and how they work in your body. Wegovy contains semaglutide, which acts as a GLP-1 receptor agonist, mimicking a natural fullness hormone that your intestines produce after eating. This prescription-only medicine works specifically on appetite regulation and gastric emptying to support weight management alongside a reduced-calorie diet and increased physical activity.
Mounjaro, by contrast, contains tirzepatide, which is a dual receptor agonist targeting both GIP and GLP-1 receptors. This difference between Wegovy and Mounjaro's mechanisms means tirzepatide works on two hormone pathways simultaneously, potentially offering different effects on blood sugar control and appetite regulation. Both medications require careful dose escalation and ongoing prescriber supervision through our GPhC-registered service.
Wegovy vs Mounjaro Pricing and Value Comparison
When comparing the difference between Wegovy and Mounjaro costs, both treatments are available through EverydayMeds with transparent pricing from £79.99. Wegovy starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. Our Intro Duo bundle (0.25mg & 0.5mg) provides the first two months of treatment for £169.99, whilst the Ultimate Stability Trio offers three months of maintenance supply at 2.4mg for £649.99.
The difference between Wegovy and Mounjaro extends to our discount structure, with new customers using code FIRST40 at checkout and returning patients applying DOSE25 for additional savings. Both treatments include comprehensive prescriber consultation, genuine medication from Novo Nordisk or Eli Lilly respectively, and next-day temperature-controlled delivery. Our bundles offer convenience rather than just cost savings, ensuring uninterrupted treatment progression without multiple orders.
Clinical Evidence: Wegovy and Mounjaro Trial Data
The difference between Wegovy and Mounjaro becomes evident when examining their respective clinical trials, though direct comparison isn't appropriate due to different study designs and populations. In the STEP trials, patients taking Wegovy alongside diet and exercise achieved an average of approximately clinically studied weight loss at 68 weeks in STEP 1, whilst STEP 5 demonstrated sustained weight loss of approximately 15.2% at two years (Wilding et al., NEJM, 2021).
Mounjaro's SURMOUNT trials showed different outcomes in separate populations, but comparing these results directly with Wegovy's STEP data would be inappropriate given the different trial methodologies and participant characteristics. Both treatments demonstrated cardiovascular benefits in their respective studies, with Wegovy's SELECT trial showing a 20% reduction in major cardiovascular events.
How Wegovy Works for Weight Management
Understanding how Wegovy functions helps clarify the difference between Wegovy and Mounjaro's approach to weight management support. Wegovy's semaglutide acts specifically on GLP-1 receptors in your brain's appetite centres, potentially reducing food cravings and promoting feelings of fullness after smaller meals. This mechanism may help you feel satisfied with reduced portion sizes, supporting your reduced-calorie diet efforts naturally. The medication also slows gastric emptying, which can contribute to prolonged satiety between meals. Clinical assessment is required to determine suitability, as Wegovy works differently for each individual and must be combined with lifestyle modifications for optimal results.
Streamlined Online Ordering Process
The difference between Wegovy and Mounjaro ordering through EverydayMeds is minimal, with both following our established three-step process for maximum convenience and safety. Begin with our three-minute online clinical assessment covering your medical history, current medications, and weight management goals, ensuring appropriate prescriber evaluation. Our qualified prescribers review your assessment within three working days (or 24 hours with express service), determining suitability for either treatment based on NICE guidelines and MHRA licensing. Once approved, your genuine medication ships via next-day cold-chain delivery, maintaining the strict temperature requirements essential for both semaglutide and tirzepatide stability. The entire process prioritises patient safety whilst ensuring rapid access to these prescription-only medicines.
Storage Requirements and Practical Considerations
A significant practical difference between Wegovy and Mounjaro concerns storage flexibility, particularly important for travel and lifestyle planning. Wegovy can remain at room temperature (below 30°C) for up to six weeks once removed from refrigeration, whilst Mounjaro requires return to fridge storage after 21 days at room temperature. Both medications must be stored at 2-8°C before first use, but Wegovy's extended room temperature tolerance offers greater convenience for holidays, business travel, or irregular schedules. The FlexTouch pen system used for Wegovy provides precise dosing with clear visual confirmation, supporting the mandatory dose escalation schedule from 0.25mg through to 2.4mg maintenance. Proper injection technique and rotation of injection sites remain important for both treatments regardless of their storage differences.
Choosing Between Wegovy and Mounjaro for UK Patients
The difference between Wegovy and Mounjaro selection depends entirely on individual medical history, treatment goals, and prescriber recommendation rather than personal preference alone. Wegovy's established track record in weight management, combined with recent cardiovascular outcome data, makes it suitable for patients seeking proven GLP-1 therapy. The longer room temperature storage period may benefit patients with active lifestyles or frequent travel requirements.
Mounjaro's dual mechanism targeting both GIP and GLP-1 receptors might appeal to patients with specific metabolic considerations, though this requires thorough prescriber evaluation. Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment aligns best with your medical profile and lifestyle requirements through our comprehensive consultation process.
Secure Online Purchase with Clinical Oversight
When you're ready to purchase either treatment, our secure platform ensures full regulatory compliance whilst maintaining the highest patient safety standards. New customers apply code FIRST40 at checkout, whilst returning patients use DOSE25 for their discount, with all prices including comprehensive prescriber consultation and medication supply. Your chosen treatment ships directly from our GPhC-registered pharmacy #9012878, with full temperature monitoring throughout the delivery process to maintain medication integrity. Whether you select Wegovy or Mounjaro, our clinical team provides ongoing support throughout your treatment journey, ensuring optimal outcomes and addressing any questions about your prescription-only medicine. Visit our Wegovy collection to begin your clinical assessment today and take the first step towards effective weight management support.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
